focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSystem1 Group Regulatory News (SYS1)

Share Price Information for System1 Group (SYS1)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 445.00
Bid: 430.00
Ask: 460.00
Change: 0.00 (0.00%)
Spread: 30.00 (6.977%)
Open: 445.00
High: 445.00
Low: 445.00
Prev. Close: 445.00
SYS1 Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update

15 Jul 2016 07:00

RNS Number : 2623E
BrainJuicer Group PLC
15 July 2016
 

 

 

 

Press Release

15 July 2016

 

 

BrainJuicer Group PLC (AIM: BJU)

("BrainJuicer", or "the Company")

 

Six month Trading Update

 

BrainJuicer, the innovative international market research agency, today releases the following six month ("H1") trading update. The Company will announce its interim results for the six months to 30 June 2016 on 16 September 2016.

 

Top line growth during H1 was generally encouraging. Revenue increased by 13%, and by 9% in constant currencies, and gross profit (our main top-line performance indicator) grew by 15%, and 11% in constant currencies. Our largest market, the US, performed strongly, with gross profit rising by some 27%; gross profit in Continental Europe and Brazil also grew well, increasing by 30% and 22% respectively. Gross profit in our second largest market, the UK, declined by 2%, and in our China and Singapore region it also declined slightly by 5%.

 

Our Ad Testing and Brand Tracking services continued to grow strongly, with gross profit up 59% year on year. Much of this business is Ongoing in nature (as opposed to Ad Hoc), and builds on the "Fame, Feeling & Fluency" approach to brand building that we introduced last year.

 

After factoring in our new creative agency, System1, which was launched during H1 and, as anticipated, incurred costs of some £0.3m, BrainJuicer's operating profit increased by some 41% to around £1.7m. After adjusting for exceptional items (share based payments and also the one-off costs in H1 2015 relating to due diligence work and our Head Office move) normalized H1 pre-tax profit will be similar to the £1.7m reported in 2015.

 

BrainJuicer's financial position remains strong. At the end of June the Company had a cash balance of £5.2m (December 2015: £6.4m), after returning £2.2m to shareholders during H1 by way of dividends and share buy-backs.

The Company generates the majority of its annual profit in the second half of the year, and whilst our revenue visibility is, as ever, limited the Board believes that the Company is in a position to meet market expectations for the full year.

 

The decline in the value of sterling versus the US Dollar, the Euro and other leading currencies following the referendum on the UK's membership of the EU benefits the Company's non-UK profits reported in sterling. The results of our overseas businesses are translated into sterling using monthly average exchange rates. Beyond this, it is too early to say what the impact of the UK's exit from the EU on the market research budgets of our clients is likely to be.

 

This announcement contains inside information. The Company can be found at www.brainjuicer.com.

 

For further information, please contact:

BrainJuicer Group PLC

Tel: +44 (0)20 7043 1000

 

John Kearon, Chief Executive Officer

 

James Geddes, Chief Financial Officer

 

Canaccord Genuity Limited

Tel: +44 (0)20 7523 8000

Simon Bridges / Henry Fitzgerald-O'Connor / Emma Gabriel

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTUSABRNWABAAR
Date   Source Headline
11th Sep 20139:51 amRNSHolding(s) in Company
7th Aug 20133:30 pmRNSHolding(s) in Company
12th Jul 201311:23 amRNSTransaction in Own Shares
11th Jul 20137:00 amRNSTrading Update
22nd May 201311:05 amRNSResult of AGM
3rd May 20132:52 pmRNSTransaction in Own Shares
16th Apr 20131:53 pmRNSNotice of AGM
15th Apr 20133:58 pmRNSAnnual Financial Report
21st Mar 20137:01 amRNSDividend Declaration
21st Mar 20137:00 amRNSResults for the 12 Months ended 31 Dec 2012
18th Jan 20133:59 pmRNSTransaction in Own Shares
17th Jan 201310:43 amRNSTrading Update
24th Dec 201211:52 amRNSTransaction in Own Shares
20th Nov 20127:00 amRNSTrading Update
26th Oct 201211:15 amRNSTransaction in Own Shares
18th Oct 20125:39 pmRNSHolding(s) in Company
15th Oct 20125:40 pmRNSTransaction in Own Shares
2nd Oct 20127:00 amRNSDirectorate Change
27th Sep 20128:02 amRNSDirector Dealing
25th Sep 20127:00 amRNSTransaction in Own Shares
20th Sep 20127:00 amRNSHalf Yearly Report
27th Jul 20128:58 amRNSUpdate of adviser details
19th Jul 20121:05 pmRNSTransaction in Own Shares
19th Jul 20127:00 amRNSTrading Statement
13th Jul 20127:00 amRNSAwards under Value Creation Plan
12th Jul 20127:38 amRNSDirector/PDMR Shareholding
6th Jul 20125:49 pmRNSTransaction in Own Shares
27th Jun 20126:06 pmRNSTransaction in Own Shares
29th May 20126:15 pmRNSTransaction in Own Shares
29th May 20124:54 pmRNSDirector dealing & appointment
23rd May 20124:23 pmRNSResult of AGM
23rd Apr 20127:00 amRNSDirector Dealing
17th Apr 20126:32 pmRNSTransaction in Own Shares
12th Apr 20125:04 pmRNSTransaction in own Shares
11th Apr 20121:46 pmRNSAnnual Report and Accounts
22nd Mar 20127:00 amRNSResults for 12 Months ended 31 Dec 2011
20th Jan 20125:39 pmRNSTransaction in Own Shares
19th Jan 20127:00 amRNSTrading Update
16th Jan 20127:47 amRNSTransaction in Own Shares
10th Jan 20122:31 pmRNSTransaction in Own Shares
5th Jan 20121:24 pmRNSDirectorate Change
2nd Dec 20117:00 amRNSTransaction in Own Shares
22nd Nov 20119:35 amRNSTransaction in Own Shares
3rd Nov 20113:23 pmRNSTransaction in Own Shares
2nd Nov 20115:39 pmRNSTransaction in Own Shares
1st Nov 20115:47 pmRNSTransaction in Own Shares
31st Oct 20114:14 pmRNSTransaction in Own Shares
29th Sep 20115:09 pmRNSDirector/PDMR Shareholding
12th Sep 20118:29 amRNSBlocklisting Interim Review
30th Aug 20119:52 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.